Applying Pharmacogenomics in Therapeutics

ISBN-13: 9781032340081 / Angielski / Miękka / 2022 / 308 str.

Xiaodong Feng; Hong-Guang Xie

Opis

This book covers the principles, practice, and potential of pharmacogenomics and personalized medicine, employing patient case profiles to illustrate key concepts and clinical applications. Featuring contributions from well-established pharmacologists/scientists, this authoritative text depicts the use of genetic biomarkers in drug discovery and

Spis treści

Concepts in Pharmacogenomics and Personalized Medicine. Principles of Pharmacogenetic Biotechnology and Testing in Clinical Practice. Essential Pharmacogenomic Biomarkers in Clinical Practice. Applying Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics and Laboratory Medicine. Clinical Applications of Pharmacogenomics in Cancer Therapy. Clinical Applications of Pharmacogenomics in Drug Therapy of Cardiovascular Diseases. Clinical Applications of Pharmacogenomics in Drug Therapy of Neurologic and Psychiatric Disorders. Applying Pharmacogenomics in the Therapeutics of Pulmonary Diseases. Pharmacogenomics and Alternative Medicine: Merge of Future and Tradition. Pharmacoeconogenomics: A Good Marriage of Pharmacoeconomics and Pharmacogenomics.

O autorze

Xiaodong Feng, PhD, PharmD, began his biomedical research career 19 years ago in the Wound Healing Center, Stony Brook School of Medicine, Stony Brook, New York, USA. He then served for four years as assistant professor in the Department of Dermatology at the State University of New York at Stony Brook, USA. Currently, Dr. Feng is professor of Pharmacology and Oncology, and Associate Dean at California Northstate University College of Medicine, Elk Grove, USA; clinical pharmacist at Sutter Davis Hospital, California, USA; and oncology pharmacy specialist at Dignity Health Medical Foundation, Rancho Cordova, California, USA.

Hong-Guang Xie, MD, PhD, earned his degrees from Central South University Xiangya School of Medicine, Changsha, China, was promoted to lecturer, and then to associate professor of pharmacology. Subsequently, he served as co-founder and associate director of the Pharmacogenetics Research Institute, Changsha, China; postdoctoral research fellow and faculty research instructor at Vanderbilt University, Nashville, Tennessee, USA; staff research fellow at the University of California Washington Center, DC, USA; and Oak Ridge Institute for Science and Education (ORISE) fellow for the United States Food and Drug Administration (US FDA). Dr. Xie is currently full professor of pharmacology and chief of the General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, China.